Display options
Cite
Goodarzi F, Hallajzadeh M, Sholeh M, et al. Biological characteristics and anti-biofilm activity of a lytic phage against vancomycin-resistant . Iran J Microbiol. 2021;13(5):691-702doi: 10.18502/ijm.v13i5.7436.
Goodarzi, F., Hallajzadeh, M., Sholeh, M., Talebi, M., Mahabadi, V. P., & Amirmozafari, N. (2021). Biological characteristics and anti-biofilm activity of a lytic phage against vancomycin-resistant . Iranian journal of microbiology, 13(5), 691-702. https://doi.org/10.18502/ijm.v13i5.7436
Goodarzi, Forough, et al. "Biological characteristics and anti-biofilm activity of a lytic phage against vancomycin-resistant ." Iranian journal of microbiology vol. 13,5 (2021): 691-702. doi: https://doi.org/10.18502/ijm.v13i5.7436
Goodarzi F, Hallajzadeh M, Sholeh M, Talebi M, Mahabadi VP, Amirmozafari N. Biological characteristics and anti-biofilm activity of a lytic phage against vancomycin-resistant . Iran J Microbiol. 2021 Oct;13(5):691-702. doi: 10.18502/ijm.v13i5.7436. PMID: 34900167; PMCID: PMC8629820.
Copy Download .nbib Format: NLM
Share it on

Iran J Microbiol. 2021 Oct;13(5):691-702. doi: 10.18502/ijm.v13i5.7436.

Biological characteristics and anti-biofilm activity of a lytic phage against vancomycin-resistant .

Iranian journal of microbiology

Forough Goodarzi, Masoumeh Hallajzadeh, Mohammad Sholeh, Malihe Talebi, Vahid Pirhajati Mahabadi, Nour Amirmozafari

Affiliations

  1. Department of Microbiology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
  2. Neuroscience Research Center, Iran University of Medical Sciences, Tehran, Iran.
  3. Cellular and Molecular Research Center, Iran University of Medical Sciences, Tehran, Iran.

PMID: 34900167 PMCID: PMC8629820 DOI: 10.18502/ijm.v13i5.7436

Abstract

BACKGROUND AND OBJECTIVES: An important leading cause of the emergence of vancomycin-resistant enterococci, especially

MATERIALS AND METHODS: A highly effective bacteriophage against vancomycin-resistant

RESULTS: Phage S2 was specifically capable of lysing a wide range of clinical

CONCLUSION: According to the results, phage S2 could potentially be an alternative for the elimination and control of vancomycin-resistant

Copyright © 2021 The Authors. Published by Tehran University of Medical Sciences.

Keywords: Antibiotic-resistance; Biofilm; Enterococcus faecium; Phage therapy; Vancomycin-resistant Enterococcus faecium

References

  1. J Infect Dev Ctries. 2014 Feb 13;8(2):129-36 - PubMed
  2. Clin Infect Dis. 2001 Oct 15;33(8):1387-92 - PubMed
  3. Viruses. 2019 Oct 16;11(10): - PubMed
  4. Curr Pharm Des. 2015;21(1):85-99 - PubMed
  5. Folia Microbiol (Praha). 2011 May;56(3):191-200 - PubMed
  6. Front Pharmacol. 2019 May 08;10:513 - PubMed
  7. Front Microbiol. 2020 Jun 12;11:1250 - PubMed
  8. Microbiol Spectr. 2015 Jun;3(3): - PubMed
  9. PLoS One. 2013;8(4):e59491 - PubMed
  10. Appl Environ Microbiol. 2008 Aug;74(15):4799-805 - PubMed
  11. Pharmaceuticals (Basel). 2015 Sep 09;8(3):559-89 - PubMed
  12. Int J Food Microbiol. 2010 Apr 15;138(3):270-5 - PubMed
  13. Open Life Sci. 2018 Dec 31;13:553-560 - PubMed
  14. Biomed Res Int. 2017;2017:9351017 - PubMed
  15. Nat Rev Microbiol. 2019 Jan;17(2):82-94 - PubMed
  16. J Gen Virol. 2014 Nov;95(Pt 11):2565-2575 - PubMed
  17. PLoS One. 2017 Mar 7;12(3):e0171317 - PubMed
  18. Arch Virol. 2018 Apr;163(4):1125-1129 - PubMed
  19. Antimicrob Agents Chemother. 2001 Apr;45(4):999-1007 - PubMed
  20. PLoS One. 2019 Jan 11;14(1):e0210218 - PubMed
  21. J Dairy Sci. 2019 May;102(5):3879-3886 - PubMed
  22. Sci Rep. 2019 Apr 30;9(1):6643 - PubMed
  23. Microbiol Res. 2018 Jul - Aug;212-213:38-58 - PubMed
  24. J Orthop Res. 2018 Jan;36(1):22-32 - PubMed
  25. Sci Rep. 2016 Dec 15;6:39235 - PubMed
  26. Curr Pharm Biotechnol. 2008 Aug;9(4):261-6 - PubMed
  27. Iran Biomed J. 2008 Oct;12(4):223-8 - PubMed
  28. Virology. 2016 May;492:11-20 - PubMed
  29. Front Microbiol. 2018 Feb 28;9:326 - PubMed
  30. BMC Microbiol. 2019 Jul 8;19(1):156 - PubMed
  31. J Infect Dis. 2016 Jul 15;214(2):189-95 - PubMed
  32. PLoS One. 2011;6(10):e26648 - PubMed
  33. PLoS One. 2018 May 15;13(5):e0195023 - PubMed
  34. J Oral Microbiol. 2016 Sep 16;8:32157 - PubMed
  35. Microb Drug Resist. 2018 Jun;24(5):590-606 - PubMed
  36. PLoS One. 2013 Nov 13;8(11):e80435 - PubMed
  37. J Biotechnol. 2017 May 20;250:29-44 - PubMed
  38. Genome Announc. 2016 Nov 17;4(6): - PubMed

Publication Types